Enter the Exosome
Simpler to produce and easier to administer than stem cell therapies – are exosomes the answer to our retinal regeneration needs?
Ben Mead |
At a Glance
- Until recently, exosomes were thought to function only as waste product excretion vehicles; in fact, they contain functional molecules that can alter the phenotype of non-cognate cells
- In particular, the ocular neuroprotective effect of stem cells – which depends on preservation of existing neurons rather than on neuroregeneration – is mediated by stem cell exosomes
- Current work demonstrates this effect in the optic crush model, where exosome-vectored microRNAs eliminate about two-thirds of the RGC death seen in untreated animals
- Stem cell-derived exosomes may form the basis for a novel, cell-free neuroprotective glaucoma therapy
Retinal stem cell therapy works – but the cells aren’t really working in the way you were promised they would back in college. It turns out that they protect the retina not by differentiating into and replacing damaged neurons, but by rescuing existing, compromised cells. But how?
Ten years ago, few would have guessed that exosomes – small extracellular vesicles that are known to assist the elimination of the by-products of cellular metabolism – had any function beyond waste management. But today, the evidence suggests that these humble structures have significant and beneficial effects in terminally differentiated neural tissues.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.